In the context of cardiovascular disease, numerous studies have demonstrated that high circulating SAA levels are independently associated with a higher risk of major adverse cardiovascular events (MACE), including myocardial infarction, stroke, and cardiovascular mortality [9,11,19]. This evidence concerns the gene SAA1 and cardiovascular disorder.